1. Cell Cycle/DNA Damage
  2. IRE1
  3. 4μ8C

4μ8C  (Synonyms: IRE1 Inhibitor III)

製品番号: HY-19707 純度: 99.95%
COA 取扱説明書 Technical Support

4μ8C (IRE1 Inhibitor III) is a small-molecule inhibitor of IRE1α.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 14003-96-4

容量 価格(税別) 在庫状況 数量
>無料サンプル (0.1 - 0.2 mg)   今すぐ申し込む  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 60 在庫あり
Solution
10 mM * 1 mL in DMSO USD 60 在庫あり
Solid
5 mg $55 在庫あり
10 mg $77 在庫あり
25 mg $132 在庫あり
50 mg $209 在庫あり
100 mg $319 在庫あり
200 mg   お問い合わせ  
500 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 69 publication(s) in Google Scholar

Top Publications Citing Use of Products

顧客検証

2D/3D Cell Culture and Differentiation
RT-PCR
WB

    4μ8C purchased from MedChemExpress. Usage Cited in: Immunity. 2025 Aug 22:S1074-7613(25)00332-2.  [Abstract]

    Representative images of mouse colon organoids treated with G'9668 or 4μ8C (10 μM) for 24 h after being differentiated with DAPT for 5 days. Scale bars, 360 μm.

    4μ8C purchased from MedChemExpress. Usage Cited in: Immunity. 2025 Aug 22:S1074-7613(25)00332-2.  [Abstract]

    Graphs depicting relative mRNA expression of Muc2 in colon organoids treated with G'9668 or 4μ8C (10 μM) for 24 h after incubation, with or without DAPT for 5 days, measured by RT-qPCR.

    4μ8C purchased from MedChemExpress. Usage Cited in: Immunity. 2025 Aug 22:S1074-7613(25)00332-2.  [Abstract]

    Graphs depicting relative mRNA expression of Agr2 in colon organoids treated with G'9668 or 4μ8C (10 μM) for 24 h after incubation, with or without DAPT for 5 days, measured by RT-qPCR.

    4μ8C purchased from MedChemExpress. Usage Cited in: Nat Metab. 2024 Aug;6(8):1601-1615.  [Abstract]

    Xbp1 splicing and Gcg expression in NaHS-treated cells in the presence of 60 μM 4μ8c for 2h (n = 4 for all groups).

    4μ8C purchased from MedChemExpress. Usage Cited in: Environ Toxicol. 2023 Jul;38(7):1756-1767.  [Abstract]

    4μ8C (20 μM; 1 h) significantly inhibits NaF-induced increased expression of p-IRE1 , GRP78 , p-TRAF2 , p-JNK, and LC3II/I in LS8 cells.

    4μ8C purchased from MedChemExpress. Usage Cited in: Toxins. 2020 Jan 16;12(1):55.  [Abstract]

    The effect of the IRE1 specific inhibitor 4μ8C on the expression of apoptosis-related proteins. The cells are exposed to FB1 with or without 4μ8C for 24 h, and the phosphorylation of JNK, Mcl-1, Bak, Bax, and Puma were analyzed by Western blotting. n = 3.
    • 生物活性

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    4μ8C (IRE1 Inhibitor III) is a small-molecule inhibitor of IRE1α.

    Cellular Effect
    Cell Line Type Value Description References
    JeKo-1 IC50
    1.57 3
    Compound: 5, 4mu8C
    Inhibition of XBP-1s expression in human Jeko cells after 24 hrs by immunoblotting analysis
    Inhibition of XBP-1s expression in human Jeko cells after 24 hrs by immunoblotting analysis
    [PMID: 24749861]
    JeKo-1 IC50
    1.57 3
    Compound: 5, 4mu8C
    Inhibition of XBP-1s expression in human Jeko cells after 24 hrs by immunoblotting analysis
    Inhibition of XBP-1s expression in human Jeko cells after 24 hrs by immunoblotting analysis
    [PMID: 24749861]
    JeKo-1 IC50
    1.57 3
    Compound: 5, 4mu8C
    Inhibition of XBP-1s expression in human Jeko cells after 24 hrs by immunoblotting analysis
    Inhibition of XBP-1s expression in human Jeko cells after 24 hrs by immunoblotting analysis
    [PMID: 24749861]
    Sf21 IC50
    206 1
    Compound: 5, 4mu8C
    Inhibition of human recombinant puritin-His-tagged IRE-1 RNase expressed in SF21 cells using XBP-1 RNA stem loop as substrate incubated for 30 mins prior to substrate addition measured after 2 hrs by FRET-suppression assay
    Inhibition of human recombinant puritin-His-tagged IRE-1 RNase expressed in SF21 cells using XBP-1 RNA stem loop as substrate incubated for 30 mins prior to substrate addition measured after 2 hrs by FRET-suppression assay
    [PMID: 24749861]
    Sf21 IC50
    206 1
    Compound: 5, 4mu8C
    Inhibition of human recombinant puritin-His-tagged IRE-1 RNase expressed in SF21 cells using XBP-1 RNA stem loop as substrate incubated for 30 mins prior to substrate addition measured after 2 hrs by FRET-suppression assay
    Inhibition of human recombinant puritin-His-tagged IRE-1 RNase expressed in SF21 cells using XBP-1 RNA stem loop as substrate incubated for 30 mins prior to substrate addition measured after 2 hrs by FRET-suppression assay
    [PMID: 24749861]
    Sf21 IC50
    206 1
    Compound: 5, 4mu8C
    Inhibition of human recombinant puritin-His-tagged IRE-1 RNase expressed in SF21 cells using XBP-1 RNA stem loop as substrate incubated for 30 mins prior to substrate addition measured after 2 hrs by FRET-suppression assay
    Inhibition of human recombinant puritin-His-tagged IRE-1 RNase expressed in SF21 cells using XBP-1 RNA stem loop as substrate incubated for 30 mins prior to substrate addition measured after 2 hrs by FRET-suppression assay
    [PMID: 24749861]
    体外実験

    When applies to the media of ER stressed cultured cells, 4μ8C (IRE1 Inhibitor III) inhibits Xbp1 splicing in a concentration-dependent manner. 4μ8C dissociates slowly from IRE1, but ishout of inhibitor leads to rapid recovery of Xbp1 splicing in cells[1].The IRE1 endoribonuclease inhibitor 4μ8c prevents the splicing of the XBP1 mRNA in response to ER stress caused by mutant proinsulin production[2]. The inositol-requiring enzyme 1α (IRE1α) is a serine-threonine kinase that plays crucial roles in activating the unfolded protein response. 4μ8C treatment dramatically inhibits IL-4 production by CD4+ T cells under Th0 conditions because both the IL-4 levels in the culture supernatant and the percentage of IL-4 positive cells are reduced by 4μ8C treatment. In addition, both IL-5 and IL-13 production are significantly reduced upon treatment with 4μ8C[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    体内実験

    4μ8c (IRE1 Inhibitor III) (i.p. injection; 10 mg/kg/day for 4 more weeks) leads to a significant reduction (45.2%) in atherosclerotic lesion area in en face aorta preparations. 4μ8c can effectively mitigate plaque development in mice[4].
    4μ8C (orally; 10, 50, or 100 mg/kg) suppresses passive cutaneous anaphylaxis (PCA) in mice (ED50 = 25.1 mg/kg)[5].
    4μ8C reverses the ER stress-dependent loss of several known RIDD targets, with an EC50 of approximately 4 μM, approximating that of inhibition of XBP1 target gene activation[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: ApoE-/- mice[4]
    Dosage: 10 mg/kg
    Administration: I.p. injection; daily; for 4 more weeks
    Result: Led to a significant reduction (45.2%) in atherosclerotic lesion area in en face aorta preparations.
    分子量

    204.18

    分子式

    C11H8O4

    CAS 番号
    Appearance

    Solid

    Color

    Light yellow to yellow

    SMILES

    O=CC1=C(O)C=CC2=C1OC(C=C2C)=O

    輸送条件

    Room temperature in continental US; may vary elsewhere.

    保管条件
    Powder -20°C 3 years
    In solvent -80°C 6 months
      -20°C 1 month
    溶剤 & 溶解度
    体外: 

    DMSO : 33.33 mg/mL (163.24 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 4.8976 mL 24.4882 mL 48.9764 mL
    5 mM 0.9795 mL 4.8976 mL 9.7953 mL
    10 mM 0.4898 mL 2.4488 mL 4.8976 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始)

    C1

    ×
    体積 (開始)

    V1

    =
    濃度 (終了)

    C2

    ×
    体積 (終了)

    V2

    体内:

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  15% Cremophor EL    85% Saline

      Solubility: 25 mg/mL (122.44 mM); Suspended solution; Need ultrasonic

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    純度とドキュメンテーション

    純度: 99.95%

    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 4.8976 mL 24.4882 mL 48.9764 mL 122.4410 mL
    5 mM 0.9795 mL 4.8976 mL 9.7953 mL 24.4882 mL
    10 mM 0.4898 mL 2.4488 mL 4.8976 mL 12.2441 mL
    15 mM 0.3265 mL 1.6325 mL 3.2651 mL 8.1627 mL
    20 mM 0.2449 mL 1.2244 mL 2.4488 mL 6.1220 mL
    25 mM 0.1959 mL 0.9795 mL 1.9591 mL 4.8976 mL
    30 mM 0.1633 mL 0.8163 mL 1.6325 mL 4.0814 mL
    40 mM 0.1224 mL 0.6122 mL 1.2244 mL 3.0610 mL
    50 mM 0.0980 mL 0.4898 mL 0.9795 mL 2.4488 mL
    60 mM 0.0816 mL 0.4081 mL 0.8163 mL 2.0407 mL
    80 mM 0.0612 mL 0.3061 mL 0.6122 mL 1.5305 mL
    100 mM 0.0490 mL 0.2449 mL 0.4898 mL 1.2244 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

     

    カスタマ需要量 *

    お名前 *

     

    タイトル

    メールアドレス *

     

    電話番号 *

    デパートメント

     

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

         

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    4μ8C
    製品番号:
    HY-19707
    数量:
    MCE 日本正規代理店: